Literature DB >> 21501111

Healthcare and guidelines: a population-based survey of recorded medical problems and health surveillance for people with Down syndrome.

Tuomo Määttä1, Joonas Määttä, Tuula Tervo-Määttä, Anja Taanila, Markus Kaski, Matti Iivanainen.   

Abstract

BACKGROUND: Medical problems are described in a population of persons with Down syndrome. Health surveillance is compared to the recommendations of national guidelines.
METHOD: Case records from the specialised and primary healthcare and disability services were analysed.
RESULTS: A wide spectrum of age-specific medical and surgical problems was described. Congenital heart defects and middle ear infections were mostly experienced by younger people, while thyroid disease, epilepsy, and Alzheimer's disease were frequent among older people. Psychiatric disorders and behavioural problems were frequent in all age groups.
CONCLUSIONS: Health surveillance remained insufficient, despite the guidelines available. A joint effort by healthcare and disability service providers is required to ensure that the medical needs of people with Down syndrome are adequately met across their entire lifespan. An active provision of healthcare and monitoring for this vulnerable group is needed.
© 2011 Australasian Society for Intellectual Disability, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21501111     DOI: 10.1080/13668250.2011.570253

Source DB:  PubMed          Journal:  J Intellect Dev Disabil        ISSN: 1366-8250


  11 in total

Review 1.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

2.  Attention Bias and Prodromal Anxiety Symptoms in Toddlers With Fragile X Syndrome and Down Syndrome.

Authors:  Kayla Smith; Abigail L Hogan; Elizabeth Will; Jane E Roberts
Journal:  Am J Intellect Dev Disabil       Date:  2021-03-01

3.  Catatonia in Down syndrome; a treatable cause of regression.

Authors:  Neera Ghaziuddin; Armin Nassiri; Judith H Miles
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-02       Impact factor: 2.570

4.  Prevalence and incidence of physical health conditions in people with intellectual disability - a systematic review.

Authors:  Peiwen Liao; Claire Vajdic; Julian Trollor; Simone Reppermund
Journal:  PLoS One       Date:  2021-08-24       Impact factor: 3.240

5.  Age and gender-related differences in quality of life of Bangladeshi patients with Down Syndrome: A cross-sectional study.

Authors:  Nafisa Nawal Islam; Ahmed Faisal Sumit; Md Mottakin Chowdhury; Md Asad Ullah; Yusha Araf; Bishajit Sarkar; David Gozal
Journal:  Heliyon       Date:  2022-01-19

6.  Low Rates of Preventive Healthcare Service Utilization Among Adolescents and Adults With Down Syndrome.

Authors:  Kristin M Jensen; Elizabeth J Campagna; Elizabeth Juarez-Colunga; Allan V Prochazka; Desmond K Runyan
Journal:  Am J Prev Med       Date:  2020-11-12       Impact factor: 5.043

7.  Epidemiology of respiratory symptoms in children with Down syndrome: a nationwide prospective web-based parent-reported study.

Authors:  Ruud H J Verstegen; Roeland W N M van Hout; Esther de Vries
Journal:  BMC Pediatr       Date:  2014-04-15       Impact factor: 2.125

8.  Health conditions and their impact among adolescents and young adults with Down syndrome.

Authors:  Terri J Pikora; Jenny Bourke; Katherine Bathgate; Kitty-Rose Foley; Nicholas Lennox; Helen Leonard
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

9.  Health comorbidities and cognitive abilities across the lifespan in Down syndrome.

Authors:  Carla M Startin; Hana D'Souza; George Ball; Sarah Hamburg; Rosalyn Hithersay; Kate M O Hughes; Esha Massand; Annette Karmiloff-Smith; Michael S C Thomas; Andre Strydom
Journal:  J Neurodev Disord       Date:  2020-01-23       Impact factor: 4.025

10.  Health care utilisation among older people with Down syndrome compared to specific medical guidelines for health surveillance: a Swedish national register study.

Authors:  G Ahlström; A Axmon; M Sandberg; E Flygare Wallén
Journal:  BMC Health Serv Res       Date:  2020-10-15       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.